Latest Breaking News On - Shreeram aradhye - Page 3 : comparemela.com

Novartis to take over MorphoSys in EUR 2.7bn deal, shares jump

Webfg. Story body

Zurich
Züsz
Switzerland
Shreeram-aradhye
Novartis
Stake
Dover
Morphosys
R2-7bn
Deal
Shares

Novartis (NVS) to buy German cancer treatment developer MorphoSys for $2.9B

Novartis (NVS) to buy German cancer treatment developer MorphoSys for $2.9B
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Vahid-karaahmetovic
Shreeram-aradhye
Novartis
Chief-medical-officer

Novartis to Acquire MorphoSys for $2.9B, Bolstering Oncology Pipeline

Novartis to Acquire MorphoSys for $2.9B, Bolstering Oncology Pipeline
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Switzerland
United-states
Swiss
Shreeram-aradhye
Jean-paul-kress
Novartis
Constellation-pharmaceuticals
Paul-kress
Novartis-partnered-morphosys

Novartis expands oncology pipeline with €2.7bn MorphoSys acquisition

Novartis expands oncology pipeline with €2.7bn MorphoSys acquisition
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Shreeram-aradhye
Incyte-jakafi
Jean-paul-kress
Novartis
Paul-kress

Novartis buys biotech MorphoSys AG for $2.9B

The move will expand Novartis’ oncology and hematology pipelines, and gives it access to pelabresib, a treatment for myelofibrosis.

Switzerland
Germany
Swiss
German
Shreeram-aradhye
Novartis